Veeva Systems (VEEV) stock

Health Care · Health Care Technology

$323.04
+$0.49 +0.15%
Close

Veeva Systems (VEEV) is a Health Care Technology company in the Health Care sector, headquartered in Pleasanton, California. As of October 23, 2026, VEEV closed at $323.04, a market capitalization of $52.30 billion, the 226th largest company in the S&P 500. Over the last twelve months it generated $3.46 billion in revenue (+18% year over year) and $1.67 billion in free cash flow. The stock trades at 53.0x trailing earnings and 31.5x forward earnings.

  • 1-year total return: +10.8% (dividends reinvested)
  • 5-year return: +0.2% a year
  • 52-week range: $148.05 – $325.99
  • Gross margin 75.0%, operating margin 29.6%
  • FI Handbook report card: B- across 10 metrics
  • 28th largest of 60 Health Care stocks in the S&P 500

VEEV price chart

1Y price change: +10.8% (price only; total returns below include dividends)

$150.00
$200.00
$250.00
$300.00
Nov2026MarMayJulSep
VEEV total returns
Total return1MYTD1Y3Y5Y10YMAX
VEEV+19.3%+44.7%+10.8%+18.3%+0.2%+23.6%+18.1%

Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 2013.

VEEV key statistics

Market cap
$52.3B
#226 in S&P 500
P/E (TTM)
53.0x
Forward P/E
31.5x
EPS (TTM)
$6.10
Revenue (TTM)
$3.5B
+18%
Free cash flow
$1.7B
Gross margin
75.0%
Operating margin
29.6%
Return on equity
14.4%
Dividend yield
None
52-week range
$148.05 – $325.99
Beta
0.93
Price / sales
15.1x
EV / EBITDA
42.0x
Debt / equity
0.02x
Employees
7,928

VEEV report card

B-

Ten fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.

  • Revenue growth17.6%B
  • Gross margin75.0%A
  • Operating margin29.6%B
  • FCF margin48.2%A
  • Return on equity14.4%C
  • Net debt / EBITDA-6.6xA
  • Forward P/E31.5xD
  • PEG ratio0.9xA
  • Shareholder yield0.3%F
  • Share count change / yr0.8%D

Veeva Systems financials

Revenue went from $550.5M in fiscal 2017 to $3.2B in fiscal 2026, growing 21.6% a year.

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Veeva Systems annual financial results
Fiscal year2017201820192020202120222023202420252026
Revenue$550.5M$690.6M$862.2M$1.1B$1.5B$1.9B$2.2B$2.4B$2.7B$3.2B
Gross profit$376.9M$479.1M$616.9M$800.7M$1.1B$1.3B$1.5B$1.7B$2.0B$2.4B
Operating income$120.7M$157.9M$222.9M$286.2M$377.8M$505.5M$459.1M$429.3M$691.4M$916.4M
Net income$77.6M$151.2M$229.8M$301.1M$380.0M$427.4M$487.7M$525.7M$714.1M$908.9M
EPS (diluted)$0.53$0.98$1.47$1.90$2.36$2.63$3.00$3.22$4.32$5.44
Free cash flow$137.1M$223.8M$302.4M$434.3M——————
Buybacks———————$0$0$169.9M
Diluted shares147.6M153.7M156.1M158.3M160.7M162.3M162.4M163.5M165.2M167.0M

Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.

PRO
15 years of financials, quarterly data and CSV export

Coming with FI Handbook Pro.

See Pro

What's priced into VEEV?

A reverse DCF asks what growth the current price requires. With an enterprise value of $45.2B and $1.7B of trailing free cash flow, Veeva Systems needs to grow free cash flow about 18.3% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return. For context, free cash flow grew 70.8% a year over the last five years.

P/E ratio history

Current 59.4x vs. median 96.9x (10th–90th percentile 58.9x–152.6x).

100x
200x
300x
2014201620182020202220242026

A model, not a forecast or advice. Small changes in assumptions move the answer a lot.

VEEV analyst price targets

27 analysts' average 12-month target is $300.56 (-7% vs. $323.04). Targets range from $180.00 to $360.00. 69% rate it a buy.

VEEV earnings

Next report: November 25, 2026. Veeva Systems has beaten EPS estimates 8 quarters in a row. Last quarter's revenue was $928.0M (+18% year over year).

Report dateEPS estimateEPS actualSurprise
Aug 26, 2026$2.22$2.35+5.8%
Jun 3, 2026$2.14$2.24+4.9%
Mar 4, 2026$1.94$2.06+6.5%
Nov 20, 2025$1.95$2.04+4.5%
Aug 27, 2025$1.90$1.99+4.8%
May 28, 2025$1.74$1.97+13.0%
Mar 5, 2025$1.58$1.74+10.1%
Dec 5, 2024$1.58$1.75+10.7%

Stocks like VEEV

NameToday1YMkt capP/E
SOLV Solventum-2.33%+18%$14.5B10.5xCompare
LLY Eli Lilly and-2.54%+56%$1.1T42.7xCompare
JNJ Johnson & Johnson-1.42%+40%$635.1B40.0xCompare
ABBV AbbVie+0.16%+29%$504.8B80.7xCompare
UNH UnitedHealth-1.62%+19%$375.3B26.9xCompare
MRK Merck &-1.34%+72%$358.4B117.2xCompare
TMO Thermo Fisher Scientific-0.40%+18%$249.1B35.5xCompare
AMGN Amgen-1.79%+54%$237.5B27.3xCompare
Make a shareable VEEV chartFree infographics for X, Reddit and your blog.

VEEV news

VEEV stock FAQ

What is VEEV's market cap?

Veeva Systems's market capitalization is $52.30 billion as of October 23, 2026, ranking 226th in the S&P 500.

What is VEEV's P/E ratio?

VEEV trades at a trailing price-to-earnings ratio of 53.0x and a forward P/E of 31.5x. Its median P/E over the period we track is 96.9x.

Does VEEV pay a dividend?

No. Veeva Systems does not currently pay a regular cash dividend.

How much has VEEV stock returned?

Including reinvested dividends, VEEV returned +10.8% over one year, +0.2% a year over five years, +23.6% a year over ten years through October 23, 2026.

Is VEEV stock overvalued?

At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies Veeva Systems must grow free cash flow about 18% a year for the next decade. Its free cash flow grew 71% a year over the last five years. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.

What is the VEEV price target?

27 analysts cover VEEV with an average 12-month price target of $300.56, -7% from the current price. 69% of them rate it a buy.

When does VEEV report earnings?

Veeva Systems is expected to report earnings on November 25, 2026. It has beaten EPS estimates 8 quarters in a row.

How many employees does Veeva Systems have?

Veeva Systems has about 7,928 full-time employees, or $436,188 of revenue per employee.

Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology